126 related articles for article (PubMed ID: 15578467)
1. Arterial versus venous sampling for activated coagulation time measurements during cardiac surgery: a comparative study.
Leyvi G; Zhuravlev I; Inyang A; Vinluan J; Ramachandran S; Lehning EJ; Wasnick JD
J Cardiothorac Vasc Anesth; 2004 Oct; 18(5):573-80. PubMed ID: 15578467
[TBL] [Abstract][Full Text] [Related]
2. Inaccuracy of coagulation studies performed on blood samples obtained from arterial catheter.
Akinci SB; Salman N; Aykut T; Kanbak M; Aypar U
J Cardiothorac Vasc Anesth; 2005 Oct; 19(5):702-3. PubMed ID: 16202916
[No Abstract] [Full Text] [Related]
3. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
Vonk AB; Veerhoek D; van den Brom CE; van Barneveld LJ; Boer C
J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152
[TBL] [Abstract][Full Text] [Related]
4. Heparinase thromboelastography compared with activated coagulation time for protamine titration after cardiopulmonary bypass.
Levin AI; Heine AM; Coetzee JF; Coetzee A
J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):224-9. PubMed ID: 24461364
[TBL] [Abstract][Full Text] [Related]
5. The effect of heparin-coated pulmonary artery catheters on activated coagulation time in cardiac surgical patients.
Haering JM; Maslow AD; Parker RA; Lowenstein E; Comunale ME
J Cardiothorac Vasc Anesth; 2000 Jun; 14(3):260-3. PubMed ID: 10890477
[TBL] [Abstract][Full Text] [Related]
6. A comparison between arterial- and venous-sampled activated clotting time measurements.
Zisman E; Rozenberg B; Katz Y; Ziser A
Isr J Med Sci; 1997 Dec; 33(12):786-8. PubMed ID: 9464347
[TBL] [Abstract][Full Text] [Related]
7. Kaolin-based activated coagulation time measured by sonoclot in patients undergoing cardiopulmonary bypass.
Ganter MT; Monn A; Tavakoli R; Klaghofer R; Zollinger A; Hofer CK
J Cardiothorac Vasc Anesth; 2007 Aug; 21(4):524-8. PubMed ID: 17678778
[TBL] [Abstract][Full Text] [Related]
8. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
Slight RD; Buell R; Nzewi OC; McClelland DB; Mankad PS
J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
[TBL] [Abstract][Full Text] [Related]
9. Prolonged Activated Clotting Time after Protamine Administration Does Not Indicate Residual Heparinization after Cardiopulmonary Bypass in Pediatric Open Heart Surgery.
Yamamoto T; Wolf HG; Sinzobahamvya N; Asfour B; Hraska V; Schindler E
Thorac Cardiovasc Surg; 2015 Aug; 63(5):397-403. PubMed ID: 26121380
[TBL] [Abstract][Full Text] [Related]
10. Hand-held personal digital assistant program for the HEMOCHRON RxDx heparin and protamine dosing system.
El Rouby S; Rinehart K; Zucker ML; LaDuca FM
J Extra Corpor Technol; 2003 Sep; 35(3):212-7. PubMed ID: 14653423
[TBL] [Abstract][Full Text] [Related]
11. Is 300 Seconds ACT Safe and Efficient during MiECC Procedures?
Bauer A; Hausmann H; Schaarschmidt J; Szlapka M; Scharpenberg M; Eberle T; Hasenkam JM
Thorac Cardiovasc Surg; 2019 Apr; 67(3):191-202. PubMed ID: 29290078
[TBL] [Abstract][Full Text] [Related]
12. Effect of heparin-bonded pulmonary artery catheters on the activated coagulation time.
McNulty SE; Maguire DP; Thomas RE
J Cardiothorac Vasc Anesth; 1998 Oct; 12(5):533-5. PubMed ID: 9801973
[TBL] [Abstract][Full Text] [Related]
13. The Hemochron Response RxDx heparin and protamine dosing system.
Jaryno SA; Zucker ML; LaDuca FM
J Extra Corpor Technol; 2004 Sep; 36(3):258-62. PubMed ID: 15559745
[TBL] [Abstract][Full Text] [Related]
14. The activated coagulation time: suitability for monitoring heparin effect and neutralization during pediatric cardiac surgery.
Martindale SJ; Shayevitz JR; D'Errico C
J Cardiothorac Vasc Anesth; 1996 Jun; 10(4):458-63. PubMed ID: 8776637
[TBL] [Abstract][Full Text] [Related]
15. Point-of-care measurement of activated clotting time for cardiac surgery as measured by the Hemochron signature elite and the Abbott i-STAT: agreement, concordance, and clinical reliability.
Dirkmann D; Nagy E; Britten MW; Peters J
BMC Anesthesiol; 2019 Sep; 19(1):174. PubMed ID: 31492108
[TBL] [Abstract][Full Text] [Related]
16. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG
J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
[TBL] [Abstract][Full Text] [Related]
17. Automated protamine dose assay in heparin reversal management after cardiopulmonary by pass.
Guarracino F; De Cosmo D; Penzo D; Tedesco M; Bossi A; Zussa C; Polesel E; De Stefani R
Minerva Anestesiol; 2001 Apr; 67(4):165-9. PubMed ID: 11376504
[TBL] [Abstract][Full Text] [Related]
18. Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial.
Meesters MI; Veerhoek D; de Lange F; de Vries JW; de Jong JR; Romijn JW; Kelchtermans H; Huskens D; van der Steeg R; Thomas PW; Burtman DT; van Barneveld LJ; Vonk AB; Boer C
Thromb Haemost; 2016 Aug; 116(2):251-61. PubMed ID: 27277211
[TBL] [Abstract][Full Text] [Related]
19. Management of anticoagulation and its reversal during paediatric cardiopulmonary bypass: a review of current UK practice.
Codispoti M; Mankad PS
Perfusion; 2000 Jun; 15(3):191-201. PubMed ID: 10866420
[TBL] [Abstract][Full Text] [Related]
20. An Adjusted Calculation Model of Reduced Heparin Doses in Cardiopulmonary Bypass Surgery in a Chinese Population.
Zhang Y; Liu K; Li W; Xue Q; Hong J; Xu J; Wu L; Ji G; Sheng J; Wang Z
J Cardiothorac Vasc Anesth; 2016 Oct; 30(5):1179-83. PubMed ID: 27475733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
